| Management number | 209063093 | Release Date | 2026/03/29 | List Price | $36.00 | Model Number | 209063093 | ||
|---|---|---|---|---|---|---|---|---|---|
| Category | |||||||||
Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management, as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals. Read more
| ISBN10 | 1108447465 |
|---|---|
| ISBN13 | 978-1108447461 |
| Edition | New |
| Language | English |
| Publisher | Cambridge University Press |
| Dimensions | 4.72 x 0.78 x 7.48 inches |
| Item Weight | 12 ounces |
| Print length | 330 pages |
| Part of series | Stahl's Essential Psychopharmacology Handbooks |
| Publication date | July 31, 2019 |
If you notice any omissions or errors in the product information on this page, please use the correction request form below.
Correction Request Form